Saudi Press

Saudi Arabia and the world
Monday, Jan 12, 2026

Facebook paid ads are promoting a horse drug as a COVID cure

Facebook paid ads are promoting a horse drug as a COVID cure

Paid adverts, Marketplace listings and closed groups are promoting a discredited drug. The experts say it's not a cure, and people shouldn't use it to treat the virus.

A drug commonly used to treat parasites in horses, cattle, and dogs is being promoted as a COVID-19 cure in Facebook groups and paid adverts hosted on the company's platforms, Euronews Next has found.

Information from Facebook's open "Ad Library" shows the company is currently showing users paid adverts that promote Ivermectin as a treatment for COVID-19. While Ivermectin is used to treat some conditions in humans, the drug is not licensed or approved for use in treating COVID-19.

Euronews Next also found evidence of closed Facebook groups that offer advice on sourcing and using Ivermectin, as well as examples of it being offered for sale on Facebook Marketplace and within Facebook groups.

Many of the active adverts on Facebook were purchased this week, days after public health officials in the US state of Mississippi announced that "at least 70 per cent" of recent calls to poison control helplines in the state were "related to ingestion of livestock or animal formulations of Ivermectin purchased at livestock supply centres".

Facebook's disinformation marketplace


A search of Facebook's Ad Library carried out by Euronews Next on August 24 revealed an array of paid adverts explicitly pushing Ivermectin as a COVID-19 treatment for humans to users in the United States.

One advert from a pharmacy chain in Louisiana claimed it was "fully stocked with Ivermectin," while another for a clinic in Arkansas said "YES I use Ivermectin to treat COVID," and claimed the drug produced positive results.

Paid adverts on Facebook make claims about Ivermectin that go against medical advice from regulators worldwide


Another advert promoting a wellness blogger's page suggested she used Ivermectin along with eating kale and blueberries to boost her immunity to disease.

The European Medicines Agency (EMA), the US Food and Drug Administration (FDA), and the World Health Organization (WHO) all say Ivermectin should only be used to treat COVID under direct medical supervision as part of controlled clinical trials.

Facebook's policy governing misleading claims in adverts on its platforms says "ads must not contain deceptive, false or misleading claims, such as those relating to the effectiveness or characteristics of a product or service".

Euronews Next asked Facebook to comment on the adverts, but the company had not responded at the time of publication.

‘Use at your own risk’


Facebook Marketplace, a service that allows users to buy and sell products, also played host to listings for Ivermectin.

One Florida-based seller offering six tubes of apple-flavoured Ivermectin paste meant for horses told Euronews Next "a lot of people" were using the drug to treat COVID-19, but claimed he "wasn't selling it for that".

"After you get it you can use it however you like," he added.

A search for "Ivermectin" in the southeastern United States brought up a number of results


When asked what the right dosage of the paste would be for a human, he said "You definitely have to use the correct dose," adding, "I have a chart but use at your own risk."

A spokesperson for the Medicines and Healthcare products Regulatory Agency (MHRA), the UK body which regulates medical products, told Euronews Next that medications must be put through robust clinical trials before being authorised for specific uses.

"A marketing authorisation for an ivermectin-containing medicine would only be issued based on robust data demonstrating a positive risk benefit for the quality, safety and efficacy of the product," they said.

No such authorisation has been obtained in the UK, US or EU.

‘For animal use only’


A search on Facebook also revealed a large number of groups devoted to Ivermectin. The largest closed group had over 25,000 members at the time Euronews Next joined.

Inside these groups were a large number of posts asking for advice on obtaining and using Ivermectin.

Some posts asked for advice on using Ivermectin. Medical regulators Euronews Next spoke to say medical advice should be sought from your doctor


Some users wanted to know how much of the drug to take, posting photos of bottles of Ivermectin clearly marked as "for animal use only".

Other posts found by Euronews Next discussed side effects of taking the drug. One user in a South Africa-based group said she was "dizzy...can't walk straight".

"My vision gets weird if I take Ivermectin a [sic] few consecutive days," said another.

The same group contained a large number of posts offering Ivermectin for sale, some of which implicitly acknowledged the drug's intended use of treating cattle and horses for parasitic worms.

One group featured a large number of posts advertising Ivermectin for sale via WhatsApp


"Moo moo juice 500ml available," one advert read, offering a price and contact number for the seller.

In February, Ivermectin maker Merck said its own analysis of studies looking at the use of the drug to treat COVID-19 found that there was "no scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies; No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease, and; A concerning lack of safety data in the majority of studies."

Anti-vaccine sentiment


Many of the groups Euronews Next joined contained anti-vaccine posts that spread disinformation about the COVID-19 vaccines.

The administrator of the largest Ivermectin group Euronews Next found claimed that "a question about self-medication as a layman, an anti-vaxxer post or a comment will be banned immediately". However, there was extensive evidence of anti-vaccine sentiment within the closed group.

Many users Euronews Next found in Ivermectin groups were hostile to COVID-19 vaccines


"No thank you, I won't be the government's guinea pig," responded one group member to a post encouraging users to get vaccinated. "There's an evil, hidden agenda at work," said another.

The most lurid posts in the group included wild and unsubstantiated claims that the COVID vaccines were poisonous and contained "nanobots," as well as the false claim that people who received the jabs would die within two years.

Euronews Next contacted Facebook to raise concerns about the Marketplace listings and the groups spreading disinformation about COVID vaccines and Ivermectin.

The social network did not comment at the time of publication.

Facebook under pressure


In recent weeks Facebook has come under increased pressure to tackle COVID-related disinformation on its platforms.

In July, US President Joe Biden criticised social media companies, saying the disinformation appearing on some platforms was "killing people".

Biden later clarified his comments, saying they referred to disinformation being spread by twelve specific Facebook accounts. The company has since said it has deleted the accounts.

Last year Facebook launched its COVID-19 Information Centre, which directs users to localised information about the pandemic in their country. The prompts appear next to posts about COVID or related topics, like the vaccine.

In a post responding to Biden's criticism, Facebook claimed that "more than 2 billion people have viewed authoritative information about COVID-19 and vaccines on Facebook," and that over 3 million Americans had used the company's vaccine checker to find their nearest place to get a jab.

But while the prompts Facebook displays can offer warnings about COVID disinformation to users, they do not prevent people from clicking links or sharing content.

"Every time I see that stupid Facebook fact check COVID warning I am compelled to read the article in depth," one user wrote under an article marked with a prompt that read "some unapproved COVID-19 treatments may cause serious harm".

Newsletter

Related Articles

Saudi Press
0:00
0:00
Close
There is no sovereign immunity for poisoning millions with drugs.
Mohammed bin Salman’s Global Standing: Strategic Partner in Transition Amid Debate Over His Role
Saudi Arabia Opens Property Market to Foreign Buyers in Landmark Reform
The U.S. State Department’s account in Persian: “President Trump is a man of action. If you didn’t know it until now, now you do—do not play games with President Trump.”
CNN’s Ranking of Israel’s Women’s Rights Sparks Debate After Misleading Global Index Comparison
Saudi Arabia’s Shifting Regional Alignment Raises Strategic Concerns in Jerusalem
OPEC+ Holds Oil Output Steady Amid Member Tensions and Market Oversupply
Iranian Protests Intensify as Another Revolutionary Guard Member Is Killed and Khamenei Blames the West
President Trump Says United States Will Administer Venezuela Until a Secure Leadership Transition
Delta Force Identified as Unit Behind U.S. Operation That Captured Venezuela’s President
Trump Announces U.S. Large-Scale Strike on Venezuela, Declares President Maduro and Wife Captured
Saudi-UAE Rift Adds Complexity to Middle East Diplomacy as Trump Signals Firm Leadership
OPEC+ to Keep Oil Output Policy Unchanged Despite Saudi-UAE Tensions Over Yemen
Saudi Arabia and UAE at Odds in Yemen Conflict as Southern Offensive Deepens Gulf Rift
Abu Dhabi ‘Capital of Capital’: How Abu Dhabi Rose as a Sovereign Wealth Power
Diamonds Are Powering a New Quantum Revolution
Trump Threatens Strikes Against Iran if Nuclear Programme Is Restarted
Why Saudi Arabia May Recalibrate Its US Spending Commitments Amid Rising China–America Rivalry
Riyadh Air’s First Boeing 787-9 Dreamliner Completes Initial Test Flight, Advancing Saudi Carrier’s Launch
Saudi Arabia’s 2025: A Pivotal Year of Global Engagement and Domestic Transformation
Saudi Arabia to Introduce Sugar-Content Based Tax on Sweetened Drinks from January 2026
Saudi Hotels Prepare for New Hospitality Roles as Alcohol Curbs Ease
Global Airports Forum Highlights Saudi Arabia’s Emergence as a Leading Aviation Powerhouse
Saudi Arabia Weighs Strategic Choice on Iran Amid Regional Turbulence
Not Only F-35s: Saudi Arabia to Gain Access to the World’s Most Sensitive Technology
Saudi Arabia Condemns Sydney Bondi Beach Shooting and Expresses Solidarity with Australia
Washington Watches Beijing–Riyadh Rapprochement as Strategic Balance Shifts
Saudi Arabia Urges Stronger Partnerships and Efficient Aid Delivery at OCHA Donor Support Meeting in Geneva
Saudi Arabia’s Vision 2030 Drives Measurable Lift in Global Reputation and Influence
Alcohol Policies Vary Widely Across Muslim-Majority Countries, With Many Permitting Consumption Under Specific Rules
Saudi Arabia Clarifies No Formal Ban on Photography at Holy Mosques for Hajj 2026
Libya and Saudi Arabia Sign Strategic MoU to Boost Telecommunications Cooperation
Elon Musk’s xAI Announces Landmark 500-Megawatt AI Data Center in Saudi Arabia
Israel Moves to Safeguard Regional Stability as F-35 Sales Debate Intensifies
Cardi B to Make Historic Saudi Arabia Debut at Soundstorm 2025 Festival
U.S. Democratic Lawmakers Raise National Security and Influence Concerns Over Paramount’s Hostile Bid for Warner Bros. Discovery
Hackers Are Hiding Malware in Open-Source Tools and IDE Extensions
Traveling to USA? Homeland Security moving toward requiring foreign travelers to share social media history
Wall Street Analysts Clash With Riyadh Over Saudi Arabia’s Deficit Outlook
Trump and Saudi Crown Prince Cement $1 Trillion-Plus Deals in High-Profile White House Summit
Saudi Arabia Opens Alcohol Sales to Wealthy Non-Muslim Residents Under New Access Rules
U.S.–Saudi Rethink Deepens — Washington Moves Ahead Without Linking Riyadh to Israel Normalisation
Saudi Arabia and Israel Deprioritise Diplomacy: Normalisation No Longer a Middle-East Priority
Saudi Arabia Positions Itself as the Backbone of the Global AI Era
As Trump Deepens Ties with Saudi Arabia, Push for Israel Normalization Takes a Back Seat
Thai Food Village Debuts at Saudi Feast Food Festival 2025 Under Thai Commerce Minister Suphajee’s Lead
Saudi Arabia Sharpens Its Strategic Vision as Economic Transformation Enters New Phase
Saudi Arabia Projects $44 Billion Budget Shortfall in 2026 as Economy Rebalances
OPEC+ Unveils New Capacity-Based System to Anchor Future Oil Output Levels
Will Saudi Arabia End Up Bankrolling Israel’s Post-Ceasefire Order in Lebanon?
×